Skip to main content
. Author manuscript; available in PMC: 2022 Oct 26.
Published in final edited form as: J Pharm Pharmacol Res. 2022 Sep 19;6(3):147–157. doi: 10.26502/fjppr.060

Table 2b:

Odds of lymph nodal metastasis, unadjusted and adjusted models (SEER 1975–2017)

Odds of lymph node metastasis Unadjusted Adjusted
Characteristics OR 95% CI OR 95% CI
Age categories
  - <40 2.08 2.04–2.12 1.74 1.71–1.78
  - 40–49 1.48 1.46–1.50 1.39 1.37–1.41
  - 50–59 1.26 1.24–1.27 1.22 1.20–1.23
  - 60–69 1 ref 1 ref
  - 70+ 0.86 0.85–0.87 0.87 0.85–0.89
Race
  - White 1 ref 1 ref
  - American Indian/Alaska Native 1.21 1.13–1.28 1.14 1.06–1.21
  - Asian or Pacific Islander 0.99 0.97–1.01 0.92 0.91–0.94
  - African American 1.41 1.39–1.43 1.23 1.21–1.25
  - Unknown 0.77 0.71–0.83 0.76 0.70–0.81
Grade
  - Well differentiated; Grade I 1 ref 1 ref
  - Moderately differentiated; Grade II 2.26 2.23–2.30 2.2 2.17–2.24
  - Poorly differentiated; Grade III 3.63 3.57–3.70 3.31 3.18–3.57
  - Undifferentiated; anaplastic; Grade IV 3.84 3.67–4.01 3.53 3.38–3.69
  - Unknown 3.32 3.25–3.39 3.23 3.17–3.30